Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Harini Jogiraju"'
Autor:
Reiji Fukano, R. Coleman Lindsley, Elena Varotto, Burgess B. Freeman, Kirsten Dickerson, Harini Jogiraju, Debbie Payne-Turner, Anang A. Shelat, Laura J. Janke, Aman Seth, Chunxu Qu, Jiyang Yu, James A. Kennedy, Emily S. Hollis, Georgia E. Haggard, Sarah M. Morris, Yingzhe Wang, Benjamin L. Ebert, Charles G. Mullighan, Ilaria Iacobucci, Rena Zheng, Jake D. Friske, Xu Yang, Nina Ghosn, Adam S. Sperling
Publikováno v:
Blood. 137:1628-1640
Acute erythroid leukemia (AEL) is characterized by a distinct morphology, mutational spectrum, lack of preclinical models, and poor prognosis. Here, using multiplexed genome editing of mouse hematopoietic stem and progenitor cells and transplant assa
Publikováno v:
Journal of Chromatography B. 1067:1-9
Pharmacokinetic, pharmacodynamic and pharmacogenomic studies of midazolam are currently being performed in critically ill children to find suitable dose regimens. Sensitive assays using small volumes of plasma are necessary to determine the concentra
Autor:
Kiran K. Pedada, Xiang Zhou, Harini Jogiraju, Samuel D. Crish, Werner J. Geldenhuys, Cornelis J. Van der Schyf, David J. Anderson, Ashta Lakshmi Prasad Gobburi
NGP1-01 (8-benzylamino-8, 11-oxapentacyclo [5.4.0.02, 6.03, 10.05, 9] undecane) is a heterocyclic cage compound with multifunctional calcium channel blocking activity that has been demonstrated to be neuroprotective in several neurodegenerative model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e002f8d694964ce5e886cf4ee248ae
https://europepmc.org/articles/PMC4744373/
https://europepmc.org/articles/PMC4744373/
Autor:
Xiang Zhou, Harini Jogiraju, David J. Anderson, Richard T. Carroll, Kiran K. Pedada, Werner J. Geldenhuys, Li Lin
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
Thiazolidinedione (TZD) compounds have shown promise as antidiabetic, antibiotics, antifungal and neuroprotective agents. The mitochondrial effect of a novel mitoNEET ligand, NL-1 {5-[(3,5-di-tert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidine-2,4-di